Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JAMP Pharma is a leading Canadian-owned pharmaceutical company headquartered in Boucherville, Quebec, specializing in the development and distribution of generic and specialty medications. Since its founding in 1988, the company has grown to offer one of the most extensive portfolios in the Canadian market, encompassing over 300 products across diverse therapeutic areas such as oncology, cardiology, and neurology. JAMP Pharma operates through several specialized divisions, including Orimed Pharma, which focuses on branded specialty products. The company has significantly expanded its presence in the biosimilars market through strategic partnerships, notably with Alvotech, to bring affordable biologic alternatives to Canadian patients. With a focus on reliability and affordability, JAMP Pharma continues to be a key player in the Canadian healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JAMP.